News Chart Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Market Closed - Hong Kong S.E. Other stock markets 01:38:17 17/05/2024 pm IST			5-day change	1st Jan Change
17.98 ^HKD	-1.21%		+4.53%	+29.35%

14/05	Shanghai Henlius Biotech Gets Go-Ahead for Clinical Trials of Breast Cancer Drug in China	MT
14/05	Shanghai Henlius Biotech, Inc. Announces Approval of Application for Clinical Trials of HLX78 (lasofoxifene) by the National Medical Products Administration	CI

59339fb36270197f2aff55e25d.Oa2QrNJDrdq70IXpFzVquYk61G_AjHPZph0D-dBjRJU.V5vj1bcxx4jrnr2MeQAY_9x55SDz-BmezVlStJIRItQIwqDt4Czuid2iyA~adf02ca8839249cfd404954f2351a4f1